Literature DB >> 10221640

Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome.

J Horiguchi1, H Yamashita, S Mizuno, Y Kuramoto, A Kagaya, S Yamawaki, Y Inami.   

Abstract

Nocturnal eating/drinking syndrome secondary to neuroleptic-induced restless legs syndrome (RLS) occurred under treatment with low-dose haloperidol in a 51-year-old female schizophrenic patient. Polysomnographic investigation showed a low level of sleep efficacy, periodic leg movements, and a strict relationship between nocturnal eating episodes and non-rapid eye movement sleep. Her nocturnal eating and RLS were completely inhibited by clonazepam treatment. To our knowledge, this is the first published case of nocturnal eating/drinking syndrome secondary to neuroleptic-induced RLS.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221640

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  12 in total

1.  Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

Authors:  Donald L Bliwise; Rebecca H Zhang; Nancy G Kutner
Journal:  Sleep Med       Date:  2014-06-13       Impact factor: 3.492

2.  Association of Restless Legs Syndrome With Incident Parkinson's Disease.

Authors:  Szabolcs Szatmari; Daniel Bereczki; Katalin Fornadi; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Miklos Z Molnar
Journal:  Sleep       Date:  2017-02-01       Impact factor: 5.849

Review 3.  Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.

Authors:  Vijaya Kumar; Ganesan Venkatasubramanian
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-12

Review 4.  Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

Review 5.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

6.  Treatment of restless legs syndrome.

Authors:  Silvia Rios Romenets; Ronald B Postuma
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

Review 7.  Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics.

Authors:  Stefan Cohrs
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

8.  Is nocturnal eating in restless legs syndrome linked to a specific psychopathological profile? A pilot study.

Authors:  Sara Marconi; Fabiano Scarlatti; Giovanni Rizzo; Elena Antelmi; Marco Innamorati; Maurizio Pompili; Roberto Brugnoli; Martino Belvederi Murri; Mario Amore; Federica Provini
Journal:  J Neural Transm (Vienna)       Date:  2015-08-02       Impact factor: 3.575

Review 9.  Beyond tremor and rigidity: non-motor features of Parkinson's disease.

Authors:  Matthias Löhle; Alexander Storch; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2009-08-14       Impact factor: 3.575

10.  Sundown syndrome in persons with dementia: an update.

Authors:  Nina Khachiyants; David Trinkle; Sang Joon Son; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2011-11-04       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.